Lysosomal acid lipase regulates bioenergetic process during the cytodifferentiation of human periodontal ligament cells

• Published in: Biochemical and biophysical research communications 2023-06, Vol.662, p.84-92
• Main Authors: Nantakeeratipat, Teerachate, Fujihara, Chiharu, Nogimori, Takuto, Matsumoto, Masahiro, Yamamoto, Takuya, Murakami, Shinya
• Format: Article
• Language: English
• Subjects: Adenosine Triphosphate; Cells, Cultured; Energy metabolism; Humans; Lysosomal acid lipase; Mineralized tissue; Oxidative Phosphorylation; Periodontal Ligament; RNA, Messenger; Sterol Esterase
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2023.04.041

Lipid metabolism is one of energy metabolic pathways that produce adenosine triphosphate (ATP). In this pathway, lysosomal acid lipase (LAL) encoded by Lipase A (LIPA), plays an important role in catalyzing lipids to fatty acids (FAs), which drive oxidative phosphorylation (OXPHOS) and generate ATP. Previously, we found that a LIPA single nucleotide polymorphism rs143793106, which decreases the LAL activity, suppressed the cytodifferentiation of human periodontal ligament (HPDL) cells. However, the mechanisms underlying that suppression are still not fully clarified. Thus, we aimed to investigate the mechanisms regulating the cytodifferentiation of HPDL cells by LAL in terms of energy metabolism. We performed the osteogenic induction of HPDL cells with or without Lalistat-2, a LAL inhibitor. To visualize lipid droplet (LD) utilization, we performed confocal microscopy on HPDL cells. We also performed real-time PCR to analyze the gene expression of calcification-related and metabolism-related genes. Furthermore, we measured the ATP production rate from two major energy production pathways, OXPHOS and glycolysis, and OXPHOS-related parameters of HPDL cells during their cytodifferentiation. We found that LDs were utilized during the cytodifferentiation of HPDL cells. Alkaline phosphatase (ALPL), collagen type 1 alpha 1 chain (COL1A1), ATP synthase F1 subunit alpha (ATP5F1A), and carnitine palmitoyltransferase 1A (CPT1A) mRNA expressions were upregulated, whereas lactate dehydrogenase A (LDHA) mRNA expression was downregulated. Additionally, total ATP production rate was significantly increased. In contrast, in the presence of Lalistat-2, LD utilization was inhibited and ALPL, COL1A1, and ATP5F1A mRNA expression was downregulated. Additionally, ATP production rate and spare respiratory capacity of the OXPHOS pathway were decreased in HPDL cells during their cytodifferentiation. Collectively, the defect of LAL in HPDL cells decreased LD utilization and OXPHOS capacity, resulting in reduced energy to sustain the adequate ATP production required for the cytodifferentiation of HPDL cells. Thus, LAL is important for periodontal tissue homeostasis as a regulator of bioenergetic process of HPDL cells. [Display omitted] •LAL inhibition by Lalistat-2 suppressed the cytodifferentiation of HPDL cells.•LAL was involved in energy metabolism during HPDL cytodifferentiation.•LAL inhibition reduced spare respiratory capacity during HPDL cytodifferentiation.